Comparison of PPV and LVOT VTI During Passive Leg Raising to Predict Fluid Responsiveness

NCT ID: NCT07304661

Last Updated: 2025-12-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

48 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-01-01

Study Completion Date

2027-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hemodynamic instability remains one of the leading causes of morbidity and mortality among critically ill patients in intensive care units. One major contributor to this instability is intravascular fluid deficit. Although fluid administration is often preferred as an initial intervention, inaccurate estimation of fluid requirements carries significant risks. Inadequate resuscitation may lead to tissue hypoperfusion and organ dysfunction, whereas excessive fluid loading is associated with pulmonary edema, increased intra-abdominal pressure, multi-organ dysfunction, and increased mortality. Consequently, reliable prediction of fluid responsiveness is considered a critical determinant in modern intensive care management.

The limited reliability of static parameters in predicting fluid responsiveness and the fact that PPV retains its validity only under specific clinical conditions highlight the need for more effective methods. In recent years, hemodynamic changes assessed during the passive leg raising (PLR) maneuver have gained prominence; particularly, left ventricular outflow tract velocity time integral (LVOT VTI)-based cardiac output measurements have been identified as a strong parameter for predicting fluid responsiveness . Moreover, changes in pulse pressure variation (PPV) during PLR have also been reported as a potential predictor; however, the number of studies prospectively comparing PPV variation and LVOT VTI-based cardiac output change within the same patient population remains limited . Therefore, the proposed study aims to fill this gap in the literature and contribute to fluid management in the intensive care setting.

The aim of this study is to compare the performance of PPV variation and LVOT VTI-based cardiac output change after the PLR maneuver in predicting fluid responsiveness among mechanically ventilated critically ill patients, and to determine the diagnostic value of both methods. The findings of the present study are expected to support more reliable decision-making in fluid therapy and provide clinical evidence toward the individualization of fluid management in intensive care practice.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is designed as a prospective observational trial. No additional intervention, procedure, or treatment beyond standard clinical practice will be performed. All data will be obtained during routine clinical management in our intensive care unit.

In mechanically ventilated patients with suspected fluid deficit, the passive leg raising (PLR) maneuver is applied as part of standard practice, during which changes in pulse pressure variation (PPV) are recorded by invasive arterial monitoring.

In this observational study, transthoracic echocardiographic (TTE) measurements of LVOT VTI will be performed by an experienced operator in addition to routine practice. Using pulse wave Doppler (PW), LVOT VTI will be recorded, and stroke volume (SV) and cardiac output (CO) will be calculated by multiplying the LVOT VTI value by the LVOT diameter. Consequently, changes in PPV and LVOT VTI-based CO during PLR will be compared.

Following TTE measurements of LVOT VTI and LVOT diameter in both the semi-recumbent position (45°) and immediately after PLR, SV and CO will be calculated. Based on these measurements, patients will be allocated into two groups:

* Fluid responsive: Patients showing ≥10% increase in LVOT VTI-based CO following PLR
* Non-fluid responsive: Patients showing \<10% change in LVOT VTI-based CO following PLR

After grouping patients accordingly, PPV changes during PLR will be compared between the two groups. This will allow evaluation of the predictive performance of PPV variation relative to LVOT VTI-based CO change in determining fluid responsiveness. All measurements will be performed by an experienced clinician without disrupting standard patient care. No additional fluid loading, invasive procedures, or therapeutic interventions will be undertaken throughout the study.

The primary aim is to compare the diagnostic performance of PPV variation and LVOT VTI-based cardiac output changes following a PLR maneuver in predicting fluid responsiveness. The study seeks to determine the diagnostic value of both methods to support more individualised fluid management.

The recorded data will include:

* Pre- and post-PLR LVOT VTI, stroke volume, cardiac output, and PPV values
* Routine monitoring parameters (systolic/diastolic blood pressure, mean arterial pressure, heart rate, and SpO₂)
* Demographic characteristics (age, sex, comorbidities) retrieved through the hospital database

Informed consent will be obtained from all participating patients or their legally authorized representatives.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemodynamic Instability Hypovolemia Critical Illness Pulse Pressure Variation

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Fluid Responsiveness Passive Leg Raising Pulse Pressure Variation LVOT VTI Cardiac Output Echocardiography

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fluid Responders

Defined as an increase in LVOT VTI-based Cardiac Output (CO) of ≥ 10% from baseline.

No interventions assigned to this group

Fluid Non-Responders

Defined as an increase in LVOT VTI-based Cardiac Output (CO) of \< 10% from baseline.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adult patients aged ≥18 years
2. Patients admitted to the intensive care unit receiving mechanical ventilation
3. Presence of suspected intravascular fluid deficit (hypotension, negative fluid balance, or clinical signs of peripheral hypoperfusion)
4. Patients in sinus rhythm
5. Presence of invasive arterial blood pressure monitoring
6. Adequate echocardiographic window allowing transthoracic echocardiographic measurement of LVOT VTI
7. Patients ventilated with tidal volume ≥8 mL/kg (ideal body weight)
8. Hemodynamically stable enough to allow measurement

Exclusion Criteria

1. Patients under 18 years of age
2. Presence of atrial fibrillation or significant arrhythmias such as frequent ventricular or atrial ectopy
3. Severe right ventricular dysfunction or significant tricuspid regurgitation
4. Advanced aortic valve disease (severe stenosis or severe regurgitation)
5. Patients with significant spontaneous breathing effort
6. Patients receiving lung-protective low tidal volume ventilation strategy (\<8 mL/kg) due to ARDS
7. Inadequate echocardiographic window for LVOT VTI assessment
8. Severe hemodynamic instability during measurement (sudden vasopressor escalation or need for resuscitation)
9. Patients who refuse to participate or from whom written informed consent cannot be obtained from themselves or a first-degree relative
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Izmir Katip Celebi University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmet Salih Tüzen, MD

Medical Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Murat Aksun

Role: PRINCIPAL_INVESTIGATOR

Izmir Katip Celebi University Atatürk Training and Research Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Izmir Katip Celebi University Atatürk Training and Research Hospital İzmir, , Turkey

Izmir, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Murat Aksun, M.D.

Role: CONTACT

Phone: +90 552 363 16 14

Email: [email protected]

Ahmet Salih Tüzen, M.D.

Role: CONTACT

Phone: +90 535 391 55 77

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Elif Ersüs, M.D.

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-SAEK-0811

Identifier Type: -

Identifier Source: org_study_id